Multicenter Study on the Long-Term (3-Year) Efficacy of Lanthanum Carbonate in Dialysis Patients

被引：0

作者：

Ando, Ryoichi ^{[1
]}

Yama, Satomi ^{[1
]}

Ohnishi, Tsuyoshi ^{[1
]}

Iwamoto, Shunsuke ^{[1
]}

Kimura, Hitoshi ^{[1
]}

Chida, Yoshiko ^{[2
]}

Ishida, Yuji ^{[3
]}

Yamada, Kouei ^{[4
]}

Inagaki, Yuichiro ^{[4
]}

Takayama, Masanobu ^{[5
]}

Tachibana, Ken ^{[6
]}

Kikuchi, Kan ^{[7
]}

Inoue, Atsushi ^{[7
]}

Ohtsuka, Masakazu ^{[8
]}

机构：

[1] Musashino Red Cross Hosp, Dept Nephrol, Tokyo, Japan

[2] Nakano Clin, Tokyo, Japan

[3] Kyonan Clin, Tokyo, Japan

[4] Kichijoji Ekimae Clin, Tokyo, Japan

[5] Takayama Clin, Tokyo, Japan

[6] Tachibana Clin, Tokyo, Japan

[7] Shimo Ochiai Clin, Tokyo, Japan

[8] Tokiwa Clin, Toride, Ibaraki, Japan

来源：

THERAPEUTIC APHERESIS AND DIALYSIS | 2014年 / 18卷

关键词：

Lanthanum Carbonate; Long-Term Effects; Management Target Values; Multicenter Study; CHRONIC KIDNEY-DISEASE; MORTALITY RISK; SERUM-CALCIUM; HEMODIALYSIS-PATIENTS; PHOSPHATE; HYPERPHOSPHATEMIA; PTH;

D O I：

10.1111/1744-9987.12206

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We previously conducted a multicenter study enrolling 101 dialysis patients with hyperphosphatemia in which lanthanum carbonate (LC) was administered for 2 years. In this study, the administration has been continued for an additional year, and we have evaluated the long-term (a total of 3 years) effects of LC. The average serum phosphorus (P) level was 6.05 mg/dL at the start and decreased to 5.84 mg/dL after 3 years, but no significant differences were observed at both points. The average serum corrected calcium (Ca) level significantly reduced after 3 years (P < 0.001). As results of evaluating the achievement rates with the management target values of serum P, Ca and intact parathyroid hormone (PTH) stated in the Japanese guideline, the achievement rates increased after 3 years. From these results, LC is considered to be a useful P binder that can be used for long-term treatment of hyperphosphatemia, without causing a Ca load.

引用

页码：2 / 8

页数：7

共 50 条

[1] Long-term efficacy and tolerability of lanthanum carbonate:: Results from a 3-year study
Hutchison, AJ
Maes, B
Vanwalleghem, J
Asmus, G
Mohamed, E
Schmieder, R
Backs, W
Jamar, R
Vosskühler, A
NEPHRON CLINICAL PRACTICE, 2006, 102 (02): : 61 - 71
[2] Multicenter Study of Long-Term (Two-Year) Efficacy of Lanthanum Carbonate
Ando, Ryoichi
Kimura, Hitoshi
Sato, Hidehiko
Iwamoto, Shunsuke
Yoshizaki, Yuki
Chida, Yoshiko
Ishida, Yuji
Takayama, Masanobu
Yamada, Kouei
Tachibana, Ken
Ohtsuka, Masakazu
Kikuchi, Kan
Inoue, Atsushi
THERAPEUTIC APHERESIS AND DIALYSIS, 2013, 17 : 2 - 8
[3] Long-term observational study in Japanese hemodialysis patients who completed a 3-year clinical study of lanthanum carbonate
Shigematsu T.
Negi S.
Ohya M.
Renal Replacement Therapy, 2 (1)
[4] LONG-TERM SAFETY, EFFICACY, AND TOLERABILITY OF LANTHANUM CARBONATE: RESULTS FROM A 3.5-YEAR STUDY
Hutchison, Alastair
NEPHROLOGY, 2005, 10 : A297 - A297
[5] Long-term safety, efficacy and tolerability of lanthanum carbonate: Results from a 3.5-year study
Hutchison, A
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V5 - V5
[6] Long-Term 3-Year Efficacy of Dupilumab in QUEST Patients Enrolled in LIBERTY ASTHMA TRAVERSE
Papi, A.
Bourdin, A.
Watz, H.
Pavord, I. D.
Domingo, C.
Wechsler, M. E.
Mao, X.
Ortiz, B.
Djandji, M.
Mannent, L. P.
Ruddy, M.
Laws, E.
Amin, N.
Lederer, D. J.
Hardin, M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
[7] Long-term experience with etanercept in psoriatic arthritis patients: A 3-year observational study
Mazzotta, Annamaria
Esposito, Maria
Schipani, Caterina
Chimenti, Sergio
JOURNAL OF DERMATOLOGICAL TREATMENT, 2009, 20 (06) : 354 - 358
[8] Long-Term Safety and Efficacy of Certolizumab Pegol in Patients with Active Non-Radiographic Axial Spondyloarthritis: 3-Year Results from a Phase 3 Multicenter Study
van der Heijde, Desiree
Gensler, Lianne
Maksymowych, Walter
Landewe, Robert
Rudwaleit, Martin
Bauer, Lars
Hoepken, Bengt
Kumke, Thomas
Kim, Mindy
Deodhar, Atul
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1896 - 1899
[9] Efficacy and safety of lanthanum carbonate in German patients on dialysis
Dellanna, Frank
Reichel, Helmut
Seibt, Frank
CLINICAL NEPHROLOGY, 2012, 78 (05) : 382 - 390
[10] Efficacy and safety of lanthanum carbonate for long-term treatment of hyperphosphataemia in patients with chronic renal failure
Hutchinson, A
Al Baaj, F
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (04) : A23 - A23

← 1 2 3 4 5 →